评估 PrimeTaper EV 种植体在单牙修复中临床效果的多中心研究
一项开放、前瞻性、多中心的调查,以评估 PrimeTaper EV 种植体在拔牙窝和愈合牙槽嵴中的临床效果 - 5 年随访
The purpose of this study is to evaluate the clinical outcome of implant survival of the PrimeTaper EV implant in single tooth restorations 1 year after permanent restoration.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adult aged 18-75 years.
- Willing and able to sign and date the informed consent form.
- In need of an implant in position 16 to 26 or 36 to 46, and each subject can only receive one implant.
- Deemed by the investigator as likely to present with an initially stable implant situation.
- A stable occlusion, i.e. an opposing natural dentition, a crown, an implant-supported fixed or removable prosthesis, a partial removable prosthesis or a full denture.
- An adjacent tooth (root with natural or artificial crown) or an implant-supported crown mesially and distally. Exemption: If the planned implant is in the first molar position, an edentulous space is accepted distally
Exclusion Criteria:
-
Not willing to participate in the clinical investigation or not able to understand the content of the clinical investigation.
-
Unlikely to be able to comply with clinical investigation procedures according to investigator's judgement.
-
Unable or unwilling to return for follow-up visits for a period of 5 years.
-
Known allergy or hypersensitivity to titanium and/or stainless steel.
-
Uncontrolled pathological process in the oral cavity, e.g. untreated rampant caries and uncontrolled periodontal disease.
-
Uncontrolled para-functional habits, e.g. bruxism.
-
Current need of any Guided Bone Regeneration (GBR) procedure in the planned implant area (gap filling at immediate placement and soft tissue grafting are allowed).
-
Systemic or local disease or condition that would compromise post-operative healing and/ or osseointegration.
-
Immunosuppression, use of corticosteroids, per-os or intravenous bisphosphonate use, or any other medication such as anti-resorptive therapy or monoclonal antibodies that could compromise post-operative healing and/or osseointegration.
-
Any other condition that would make the subject unsuitable for participation, including but not limited to;
- History of radiation therapy in the head and neck region.
- History of chemotherapy within 5 years prior to surgery.
- Present alcohol and/or drug abuse.
- Ongoing psychiatric illness.
- Current smoking/use of tobacco, including e-cigarettes.
-
Any ongoing disease that would make the subject unsuitable for participation, including but not limited to;
- Recent myocardial infarction (< 3 months*).
- Recent cerebrovascular accident (< 3 months*).
- Recent cardiac-valvular prosthesis placement (< 3 months*).
- Hemorrhagic diathesis.
- Severe liver dysfunction.
- Known or suspected current malignancy.
- Uncontrolled diabetes mellitus.
- Florid infection.
-
Pregnant or breastfeeding females. (Pregnancy tests will be performed as per local requirements).
-
Previous enrolment in the present clinical investigation.
-
Involvement in the planning and conduct of the clinical investigation (applies to both Dentsply Sirona staff and the clinical investigation site).
-
Simultaneous participation in another clinical investigation, or participation in a clinical investigation during the last 6 months that may interfere with the present clinical investigation.
- < 3 months is a strict exclusion criterion. After 3 month it is up to the investigator to judge whether the subject is considered suitable for participation or not.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Single tooth restorations
A single, open-label group with patients in need of single tooth restorations will receive PrimeTaper EV implant system with diameters 3.6, 4.2, 4.8, 5.4 mm, and lengths 6.5, 8, 9, 11, 13, 15 and 17 mm. |
Tapered dental implant developed by Dentsply Sirona |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Implant Survival, i.e. Number of Implants in Place Counted Clinically, 1 Year After Permanent Restoration.
大体时间:One year post permanent restoration (anticipated average 3 months after implant placement).
|
Implant survival rate is a binary variable evaluated clinically, i.e. 'Yes' or 'No' where 'Yes' means that the implant is still in place and 'No' means that the implant is not in place. Any implant that has been removed or lost after implant placement visit will be considered a failure, whatever the reason for removal/loss. |
One year post permanent restoration (anticipated average 3 months after implant placement).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Implant Survival, i.e. Number of Implants in Place Counted Clinically, 2, 3, 4 and 5 Years After Permanent Restoration.
大体时间:2, 3, 4 and 5 years post permanent restoration (anticipated average 3 months after implant placement).
|
Implant survival rate is a binary variable evaluated clinically, i.e. 'Yes' or 'No' where 'Yes' means that the implant is still in place and 'No' means that the implant is not in place. Any implant that has been removed or lost after implant placement visit will be considered a failure, whatever the reason for removal/loss. |
2, 3, 4 and 5 years post permanent restoration (anticipated average 3 months after implant placement).
|
|
Change of Implant Stability Quotient Value (ISQ) Between Implant Placement and Permanent Restoration.
大体时间:From date of implant placement (anticipated average 1 month after inclusion) to date of permanent restoration (anticipated average 3 months after implant placement).
|
Implant stability will be evaluated through ISQ value using Resonance Frequency Analysis (RFA). The stability is presented as an ISQ value. The higher the ISQ value the higher the stability. Recorded as a numeric value (1-100). |
From date of implant placement (anticipated average 1 month after inclusion) to date of permanent restoration (anticipated average 3 months after implant placement).
|
|
Maximum Insertion Torque Value for Each Implant at Implant Placement.
大体时间:At date of implant placement (anticipated average 1 month after inclusion).
|
Maximum insertion torque value (ITV), based on ITV curve, measured in Ncm. |
At date of implant placement (anticipated average 1 month after inclusion).
|
|
Final Insertion Torque Value for Each Implant at Implant Placement.
大体时间:At date of implant placement (anticipated average 1 month after inclusion).
|
Final insertion torque value (ITV), based on ITV curve, measured in Ncm. |
At date of implant placement (anticipated average 1 month after inclusion).
|
|
Investigator Questionnaire for Each Investigational Medical Device After Implant Placement.
大体时间:Immediately after implant placement (anticipated average 1 month after inclusion).
|
Numerical scale 1-10, where 1 = totally disagree with the statement, and 10 = totally agree with the statement. Statements to be evaluated by the surgeon: "The implant was guided into the prepared osteotomy", "The implant followed the prepared osteotomy", "The implant has a good primary stability", "The drilling protocol is easy to use", "The implant has efficient cutting properties". Each statement will be evaluated separately. |
Immediately after implant placement (anticipated average 1 month after inclusion).
|
|
Implant Success, i.e., Number of Implants Documented as Successful at 1, 2, 3 and 5 Years After Permanent Restoration.
大体时间:1, 2, 3 and 5 years post permanent restoration (anticipated average 3 months after implant placement).
|
Successful implants counted, i.e. 'Yes' or 'No'. An implant will be considered successful if all of the following criteria are fulfilled:
|
1, 2, 3 and 5 years post permanent restoration (anticipated average 3 months after implant placement).
|
|
Change of Marginal Bone Level up to 5 Years Post Permanent Restoration Compared to Permanent Restoration.
大体时间:At permanent restoration (anticipated average 3 months after implant placement) and 1, 2, 3 and 5 years post permanent restoration.
|
MBL changes determined from radiographs, expressed as the distance from the implant reference point to the most coronal bone-to-implant contact on the mesial and distal side of the implant. The average will be calculated and compared for each evaluation period. |
At permanent restoration (anticipated average 3 months after implant placement) and 1, 2, 3 and 5 years post permanent restoration.
|
|
Change of Probing Pocket Depth (PPD) in mm Between Permanent Restoration, and 6 Months, 1, 2, 3, 4 and 5 Years After Permanent Restoration.
大体时间:At permanent restoration (anticipated average 3 months after implant placement) and 6 months, 1, 2, 3, 4 and 5 years post permanent restoration.
|
Probing Pocket Depth (PPD) measured as the distance from the mucosal margin to the bottom of the probe-able pocket in mm. |
At permanent restoration (anticipated average 3 months after implant placement) and 6 months, 1, 2, 3, 4 and 5 years post permanent restoration.
|
|
Presence of Bleeding on Probing (BoP), at Permanent Restoration, and 6 Months, 1, 2, 3, 4 and 5 Years After Permanent Restoration.
大体时间:At permanent restoration (anticipated average 3 months after implant placement) and 6 months, 1, 2, 3, 4 and 5 years post permanent restoration.
|
Bleeding on Probing (BoP) recorded as presence or absence of bleeding when probing to the bottom of the pocket. |
At permanent restoration (anticipated average 3 months after implant placement) and 6 months, 1, 2, 3, 4 and 5 years post permanent restoration.
|
|
Presence of Plaque at 6 Months, 1, 2, 3, 4 and 5 Years After Permanent Restoration.
大体时间:6 months, 1, 2, 3, 4 and 5 years post permanent restoration (anticipated average 3 months after implant placement).
|
Plaque recorded as presence or absence of plaque by visual inspection on four surfaces at each implant site. |
6 months, 1, 2, 3, 4 and 5 years post permanent restoration (anticipated average 3 months after implant placement).
|
|
Occurrence of Adverse Events, Adverse Device Effects, and Device Deficiencies During the Clinical Investigation.
大体时间:Up to 5 years after permanent restoration (anticipated average 3 months after implant placement).
|
Adverse Events, Adverse Device Effects, and Device Deficiencies spontaneously reported, and collection at each clinical investigation visit. |
Up to 5 years after permanent restoration (anticipated average 3 months after implant placement).
|
合作者和调查者
调查人员
- 首席研究员:Andy Temmerman, Prof.、KU Leuven
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.